Back to Search Start Over

Toward in vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosis.

Authors :
Schreiber S
Schreiber F
Garz C
Debska-Vielhaber G
Assmann A
Perosa V
Petri S
Dengler R
Nestor P
Vielhaber S
Source :
Muscle & nerve [Muscle Nerve] 2019 May; Vol. 59 (5), pp. 567-576. Date of Electronic Publication: 2019 Mar 08.
Publication Year :
2019

Abstract

Introduction: We sought to identify patients with amyotrophic lateral sclerosis (ALS) who displayed suspected peripheral nervous system (PNS) inflammation to compare them to those with suspected PNS degeneration.<br />Methods: We measured sonographic median and ulnar nerve cross-sectional area (CSA) and cerebrospinal fluid albumin/serum albumin ratio (Q <subscript>alb</subscript> ) in patients with ALS to classify them as having suspected PNS degeneration (small CSA/low Q <subscript>alb</subscript> ) or inflammation (larger CSA/high Q <subscript>alb</subscript> ).<br />Results: Fifty-seven percent of patients had suspected PNS degeneration, 21% had suspected PNS inflammation, and 21% displayed suspected "normal PNS state." Suspected PNS degeneration was related to classic ALS, shorter disease duration, and a smaller hypoechoic nerve area. Suspected PNS inflammation was associated with men, longer disease duration, and a larger hypoechoic nerve area and was the dominant finding in superoxide dismutase 1 mutation carriers.<br />Discussion: Our simple approach might aid in the in vivo differentiation of supposed ALS subtypes, those with suspected PNS degeneration vs. inflammation, for stratification in clinical trials. Muscle Nerve 59:567-567, 2019.<br /> (© 2019 Wiley Periodicals, Inc.)

Details

Language :
English
ISSN :
1097-4598
Volume :
59
Issue :
5
Database :
MEDLINE
Journal :
Muscle & nerve
Publication Type :
Academic Journal
Accession number :
30734322
Full Text :
https://doi.org/10.1002/mus.26444